,

PRIM reaches an agreement with Laboratorios Milo to purchase its Parapharmacy, Orthopaedic and Podiatry ranges.

This operation "strengthens" the Prim group’s presence in the Pharmaceutical sector and enables it to continue to enhance its growth strategy within the healthcare industry thanks to the complementary nature of both companies’ structures…